Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection
Fubing Li, Yang Li, Huichun Liang, Tao Xu, Yanjie Kong, Maobo Huang, Ji Xiao, Xi Chen, Houjun Xia, Yingying Wu, Zhongmei Zhou, Xiaomin Guo, Chunmiao Hu, Chuanyu Yang, Xu Cheng, Ceshi Chen, Xiaopeng Qi
Fubing Li, Yang Li, Huichun Liang, Tao Xu, Yanjie Kong, Maobo Huang, Ji Xiao, Xi Chen, Houjun Xia, Yingying Wu, Zhongmei Zhou, Xiaomin Guo, Chunmiao Hu, Chuanyu Yang, Xu Cheng, Ceshi Chen, Xiaopeng Qi
View: Text | PDF
Research Article Immunology Infectious disease

HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection

  • Text
  • PDF
Abstract

Lysine-63–linked (K63-linked) polyubiquitination of TRAF3 coordinates the engagement of pattern-recognition receptors with recruited adaptor proteins and downstream activator TBK1 in pathways that induce type I IFN. Whether autoubiquitination or other E3 ligases mediate K63-linked TRAF3 polyubiquitination remains unclear. We demonstrated that mice deficient in the E3 ligase gene Hectd3 remarkably increased host defense against infection by intracellular bacteria Francisella novicida, Mycobacterium, and Listeria by limiting bacterial dissemination. In the absence of HECTD3, type I IFN response was impaired during bacterial infection both in vivo and in vitro. HECTD3 regulated type I IFN production by mediating K63-linked polyubiquitination of TRAF3 at residue K138. The catalytic domain of HECTD3 regulated TRAF3 K63 polyubiquitination, which enabled TRAF3-TBK1 complex formation. Our study offers insights into mechanisms of TRAF3 modulation and provides potential therapeutic targets against infections by intracellular bacteria and inflammatory diseases.

Authors

Fubing Li, Yang Li, Huichun Liang, Tao Xu, Yanjie Kong, Maobo Huang, Ji Xiao, Xi Chen, Houjun Xia, Yingying Wu, Zhongmei Zhou, Xiaomin Guo, Chunmiao Hu, Chuanyu Yang, Xu Cheng, Ceshi Chen, Xiaopeng Qi

×

Figure 2

HECTD3 deficiency is protective against Mycobacterium and Listeria infections, but not E. coli infection.

Options: View larger image (or click on image) Download as PowerPoint
HECTD3 deficiency is protective against Mycobacterium and Listeria infec...
(A–C) Hectd3–/– (KO) mice and littermate WT controls were intranasally infected with GFP-expressing BCG (7.5 × 106 CFUs per mouse), and bacterial burden in the lung on day 2 was determined by BCG genomic DNA PCR (A) and CFU analysis (B). H&E staining of lung sections from WT and Hectd3–/– mice on day 2 after infection (C). Arrowhead indicates infiltrated immune cells. (D–H) Hectd3–/– mice and littermate WT controls were intraperitoneally infected with L. monocytogenes (6.0 × 104 CFUs per mouse). Loss in body weight was determined (D), and bacterial burden in the spleen and liver was analyzed on day 2 after infection (E). (F) H&E staining of liver sections from WT and Hectd3–/– mice on day 2 after infection with L. monocytogenes. Arrowhead indicates infiltrated immune cells. (G) Expression of genes encoding TNF-α, IL-6, and IFN-β was analyzed in liver tissues from WT and Hectd3–/– mice on day 2 after infection with L. monocytogenes. (H) Liver tissue samples from WT and Hectd3–/– mice on day 2 after infection with L. monocytogenes were homogenized, and lysates were analyzed for activation and expression of caspase-3, caspase-11, ZBP1, and HECTD3. GAPDH was used as loading control. (I–K) Hectd3–/– mice and littermate WT controls were intraperitoneally infected with E. coli (1.0 × 108 CFUs per mouse), and loss in body weight was determined (I), bacterial burden in the spleen and liver was analyzed on day 2 after infection (J), and production of TNF-α and IL-6 (K) was analyzed from WT and Hectd3–/– mice on day 2 after infection with E. coli. Each symbol indicates an individual mouse (A, B, E, G, and J). Data represent 2 independent experiments and are presented as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts